Stay updated on BCG & ALT-803 Combo in BCG Unresponsive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the BCG & ALT-803 Combo in BCG Unresponsive Bladder Cancer Clinical Trial page.

Latest updates to the BCG & ALT-803 Combo in BCG Unresponsive Bladder Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page has been updated to reflect a new revision version (v2.15.0) and a new date (2025-04-13), replacing the previous revision (v2.14.4) and date (2024-04-08).SummaryDifference2%
- Check42 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check85 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check100 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check107 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
Stay in the know with updates to BCG & ALT-803 Combo in BCG Unresponsive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCG & ALT-803 Combo in BCG Unresponsive Bladder Cancer Clinical Trial page.